Inactive Instrument

News Microbot Medical Inc Nasdaq

Equities

US59503A1051

Summary

Unlock all the news: Be the first to know and act before the market!

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial	Jul. 09	GL
Microbot Medical Enrolls First Patient in Human Clinical Trial of Liberty Surgical System	Jul. 08	MT
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial	Jul. 08	GL
Microbot Medical Enrolled the First Patient in Its Pivotal Human Clinical Trial	Jul. 08	CI
Microbot Medical Signs Clinical Trial Deal With Baptist Hospital of Miami	Jul. 03	MT
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial	Jul. 03	GL
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial	Jun. 20	GL
Microbot Medical Inc Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial	Jun. 20	CI
Microbot Medical Inc. announced that it has received $1.762502 million in funding	Jun. 19	CI
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial	Jun. 17	GL
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial	Jun. 17	AQ
Microbot Medical Files Common Stock Registration Statement	Jun. 11	MT
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	Jun. 04	GL
Sector Update: Health Care Stocks Gain Late Afternoon	Jun. 03	MT
Microbot Gets FDA Nod to Start Trial, to Raise $2.35 Million From Direct Offering Deal; Shares Soar	Jun. 03	MT
Top Midday Gainers	Jun. 03	MT
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	Jun. 03	GL
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial	Jun. 03	GL
Microbot Medical Inc. Has Received FDA Approval to Proceed with Its Pivotal Human Clinical Trial	Jun. 03	CI
Microbot Medical Inc. announced that it expects to receive $1.762502 million in funding	Jun. 02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Microbot Medical Inc Nasdaq

Equities

US59503A1051

Summary

Filters